Literature DB >> 34743921

Single B cell technologies for monoclonal antibody discovery.

Alessandro Pedrioli1, Annette Oxenius2.   

Abstract

Monoclonal antibodies (mAbs) are often selected from antigen-specific single B cells derived from different hosts, which are notably short-lived in ex vivo culture conditions and hence, arduous to interrogate. The development of several new techniques and protocols has facilitated the isolation and retrieval of antibody-coding sequences of antigen-specific B cells by also leveraging miniaturization of reaction volumes. Alternatively, mAbs can be generated independently of antigen-specific B cells, comprising display technologies and, more recently, artificial intelligence-driven algorithms. Consequently, a considerable variety of techniques are used, raising the demand for better consolidation. In this review, we present and discuss the major techniques available to interrogate antigen-specific single B cells to isolate antigen-specific mAbs, including their main advantages and disadvantages.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34743921     DOI: 10.1016/j.it.2021.10.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  6 in total

1.  Microarray-guided evaluation of the frequency, B-cell origins, and selectivity of human glycan-binding antibodies reveals new insights and novel antibodies.

Authors:  J Sebastian Temme; Jennifer A Crainic; Laura M Walker; Weizhun Yang; Zibin Tan; Xuefei Huang; Jeffrey C Gildersleeve
Journal:  J Biol Chem       Date:  2022-09-08       Impact factor: 5.486

Review 2.  Antibodies to combat viral infections: development strategies and progress.

Authors:  Giuseppe Pantaleo; Bruno Correia; Craig Fenwick; Victor S Joo; Laurent Perez
Journal:  Nat Rev Drug Discov       Date:  2022-06-20       Impact factor: 112.288

Review 3.  High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Authors:  Nicola Zambrano; Guendalina Froechlich; Dejan Lazarevic; Margherita Passariello; Alfredo Nicosia; Claudia De Lorenzo; Marco J Morelli; Emanuele Sasso
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

Review 4.  Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing.

Authors:  Jason R Burchett; Jordan M Dailey; Sydney A Kee; Destiny T Pryor; Aditya Kotha; Roma A Kankaria; David B Straus; John J Ryan
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

5.  An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.

Authors:  Fu-Fei Hsu; Kang-Hao Liang; Monika Kumari; Wan-Yu Chen; Hsiu-Ting Lin; Chao-Min Cheng; Mi-Hua Tao; Han-Chung Wu
Journal:  Int J Pharm       Date:  2022-10-02       Impact factor: 6.510

Review 6.  Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies.

Authors:  Brian A Baldo
Journal:  Antibodies (Basel)       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.